Seraxis, Inc. | Finanzwire

BRIEF

published on 06/14/2024 at 15:05, 6 months 7 days ago

Seraxis Secures $400,000 Maryland Stem Cell Research Fund Grant for Pancreatic Islet Replacement Therapy

Stem Cell Research Seraxis Pancreatic Islet Replacement Type 1 Diabetes MSCRF Grant
PRESS RELEASE

published on 06/14/2024 at 15:00, 6 months 7 days ago

Seraxis Wins Maryland Stem Cell Research Fund Grant to Accelerate Development of Allogenetically Compatible Pancreatic Islet Replacement Therapy for Functional Cure of T1D
Seraxis, Inc. awarded $400,000 MSCRF grant to advance SR-03 cell line for diabetes treatment. Meeting at ADA Annual Meeting in Orlando

Diabetes Treatment MSCRF Grant Seraxis Inc. SR-03 Cell Line ADA Annual Meeting
PRESS RELEASE

published on 01/04/2024 at 15:00, 11 months 17 days ago

Seraxis' Manufacturing Suite Completes GMP Quality System Audit Ahead of SR-02 IND Filing and Transplantation of Pancreatic Clusters to Patients With Type 1 Diabetes
Seraxis, Inc., a regenerative medicine company, has announced the completion of a GMP-compliant manufacturing audit for its pancreatic islet replacement therapy program. The audit revealed no critical or major observations, positioning the company's SR-02 as one of the industry's leading clinical-stage stem cell-derived pancreatic islet transplant programs. CEO Dr. William Rust will present further data on the development of SR-02 and follow-on immune-cloaked SR-03 at Biotech Showcase in San Francisco.

Seraxis Inc GMP-compliant Manufacturing Pancreatic Islet Transplant Program Stem Cell-derived Therapy Biotech Showcase

Published on 12/21/2024 at 01:30, 17 hours 27 minutes ago

Quantum Biopharma Announces Closing of Second Tranche
Published on 12/21/2024 at 01:30, 17 hours 27 minutes ago

iMetal Resources Closes First Tranche of Previously Announced Non-Brokered Private Placement
Published on 12/21/2024 at 00:05, 18 hours 52 minutes ago

Chloeta Awarded GSA OASIS+ IDIQ Contract for Intelligence, Federal Civilian and Defense Support Services
Published on 12/21/2024 at 00:00, 18 hours 57 minutes ago

Amarc Announces Loan Extension
Published on 12/20/2024 at 23:30, 19 hours 27 minutes ago

Boron One Announces Extension to Early Warrant Exercise Incentive Program

View all ACCESSWIRE

Published on 12/21/2024 at 00:51, 18 hours 5 minutes ago

Acquisition of PSI Transcom GmbH by CHAPTERS platform Altamount Software GmbH
Published on 12/21/2024 at 00:45, 18 hours 11 minutes ago

EQS-Adhoc: PSI sells the Mobility business unit
Published on 12/20/2024 at 19:10, 23 hours 46 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 12/20/2024 at 18:56, 1 day ago

CPI PROPERTY GROUP – Progress on Key Initiatives
Published on 12/20/2024 at 18:00, 1 day ago

ARYZTA AG Announces New Board Technology Committee

View all EQS

Published on 12/21/2024 at 12:17, 6 hours 39 minutes ago

AXA announces the signing of a share purchase agreement with BNP Paribas relating to the sale of AXA IM
Published on 12/20/2024 at 18:00, 1 day ago

Capital increase through exercise of subscription rights
Published on 12/20/2024 at 17:55, 1 day 1 hour ago

Disclosure of trading in own shares from 16/12/2024 to 20/12/2024
Published on 12/20/2024 at 14:00, 1 day 4 hours ago

Safran: Woodward Signs Agreement to Acquire Safran’ s Electromechanical Actuation Business based in North America
Published on 12/19/2024 at 18:30, 2 days ago

Share capital decrease by way of treasury shares cancellation

View all LES ECHOS COMFI WIRE

News